Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Hikmat N Abdel-Razeq
    Deputy Director General
    King Hussein Cancer Center
    University of Jordan
    Jordan
    habdelrazeq@KHCC.JO
    GJCT

    Research Interest: Clinical Oncology

    More Info.
    Jinbo Gao
    Department of Gastrointestinal Surgery
    Huazhong University of Science and Technology
    China
    gaojinbo@163.com
    GJCT

    Research Interest:  Gastric Cancer; Colon Cancer; Rectal Cancer; Interferon Regulatory Factor-1 (IRF-1); Chemotherapy; Drug Resistance; Telomerase

    More Info.
    Rui-An Wang
    Professor
    Department of Pathology and Pathobiology
    The Fourth Military Medical University
    China
    wangra@fmmu.edu.cn
    GJCT

    Research Interest: Theory and Mechanisms of Carcinogenesis and Metastasis; Breast Cancer; Endocrinology


    More Info.
    Peng Zhan
    Associate Professor
    Shandong University,
    China
    zhanpeng1982@163.com
    GJCT

    Research Interest: Discovery of Novel Antiviral, Anticancer and Neurodegenerative Diseases-Related Agents Based on The Rational Drug Design Approaches.


    More Info.
    Raj Kumar Koiri
    Assistant Professor
    Department of Zoology
    Dr. Hari Singh Gour Central University
    India
    rkkoiri@dhsgsu.ac.in
    GJCT

    Research Interest: To study the metabolic adaptation for survival occurring in the cancer cells

    More Info.
    Wang Fan
    Attending Physician
    The First Peoples Hospital of Jingmen
    China
    wangfan19840303@126.com
    GJCT

    Research Interest: Glioma, Circadian Gene, Radiotherapeutic Sensitivity, Carcinogenesis

    More Info.
    Yan Baglo
    Research Fellow
    Fischell Department of Bioengineering
    University of Maryland
    USA
    ybaglo@umd.edu
    GJCT

    Research Interest: Cancer treatment regimens, photodynamic therapy, nanotechnology-enabled drug delivery.

    More Info.
    Varun Mittal
    Hematology and Oncology
    Albert Einstein Healthcare Network
    USA
    Varun.doc7@gmail.com
    GJCT

    Research Interest: Population Based Analysis of Cancer Database, Lung Carcinoma

    More Info.
    Mostafa Shawky Ibrahim El-Haddad
    Assistant Professor
    Department of Clinical Oncology
    Cairo University
    Egypt
    mostafa@mostafaelhaddad.com
    GJCT

    Research Interest:  Highly Interested in Modern, Advanced Radiotherapy Techniques such as IMRT IGRT, Adaptive Radiotherapy and How to Use Them to Improve the Treatment Outcome of Cancer Patients

    More Info.
    Patrizio Lancellotti
    Professor
    Cardiology
    University of Liege
    Belgium
    plancellotti@chu.ulg.ac.be
    GJCT

    Research Interest: New Insights Into The Development And Progression Of Aortic Valvestenosis (Thenid-¬‐PAS Study) Progression And Outcome Of Secondary Mitral Regurgitation (POMAR Registry)Radiation-¬‐Induced Heart Disease (AVRI Study): Animal Study Normal Reference Ranges For Echocardiography: Rationale, Study Design And Methodology(NORRE Study)


    More Info.
    Ryou-U Takahashi
    Division of Molecular and Cellular Medicine
    National Cancer Center Research Institute
    Japan
    rytakaha@ncc.go.jp
    GJCT

    Research Interest: Molecular And Cell Biology, Microrna, Breast Cancer, Cancer Stem Cells


    More Info.
    Mine Yarim
    Professor
    Yeditepe University
    Turkey
    myarim@yeditepe.edu.tr
    GJCT

    Research Interest: The Synthesis and Evaluation of New Molecules for Anticancer Activity; QSAR and Drug Design; HPLC and Chiral Separation

    More Info.
    Maryam Azimi Mohammadabadi
    Department of Immunology
    Tehran University of Medical Science
    Iran
    m-azimim@razi.tums.ac.ir
    GJCT

    Research Interest: Potential Therapeutic Applications of Arteether, a Semi-Synthetized Derivative of Artemisinin on a Murine Model of Breast Cancer. As a Result, I Have Got Some Experience Atan Area of Tumor Immunology/Immunotherapynamed "Chemoimmunotherapy". Chemoimmunotherapy is an Approach for the Treatment of Cancers in Whichthe Focus is to enhance the Efficacy of chemotherapeutic Agents by Concomitant Application of Compounds with Immunomodulatory Properties. Besides my Thesis Work, I Managed to Do a Course in Cellular Immunology with Professor Hassan, One of the Well-Knownimmunologists in Iran, so that i could also Work on Cellular Immunology Aspects of Tumors. Moreover, Considering the Reported Associations between Molecular Players such as CTLA-4, PDL-1 and also Different Micrornas in Tumor Progression, i am Currently Planning to further Study these Associations in order to improve the Efficacy of Tumor Immunotherapy

    More Info.
    Hamidreza Montazeri
    Assistant Professor
    University of Alberta
    Canada
    hm1@ualberta.ca
    GJCT

    Research Interest: My Research Interests Include Targeted Delivery, Sirna Silencing, Apoptosis, Cancer Treatment, Multi-Drug Resistance, And Pharmaceutics In General


    More Info.
    Muzafar Ahmad Macha
    Department of Biochemistry
    Molecular Biology University Nebraska Medical Center
    USA
    muzafar.macha@unmc.edu
    GJCT

    Research Interest : Animal handling: Oral cavity/pancreatic cancer orthotopic and subcutaneous xenograft models; Protein technology: Protein estimation, SDS PAGE, western blotting, 2D gel electrophoresis, Immunoprecipitation; Recombinant DNA technology: bacterial culture and preparation of competent cells; Cell culture technique: isolation of genomic plasmid/DNA/RNA isolation, PCR, RT-PCR, Real time PCR, Electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (CHIP), cell proliferation and viability assays, invasion and motility assay, scratch assay, immunocytochemistry, confocal laser scan microscopy, FACS analysis, ELISA, immunohistochemistry


    More Info.
    View more
    mendeley

    Contribution of viruses to cancer and its global burden

    DOI Logo 10.17352/2581-5407.000025

    Published On: August 20, 2019 | Pages: 012 - 015

    Author(s): Shahzeb Khan Shaz*
    Abstract View Full Article View
    mendeley

    A Novel Nutrient Mixture Induces Apoptosis in Human Mesothelioma Cells (MSTO-211H) via Activation of Caspases

    DOI Logo 10.17352/2581-5407.000024

    Published On: April 09, 2019 | Pages: 007 - 011

    Author(s): M Waheed Roomi, Bilwa Bhanap, Aleksandra Niedzwiecki* and Matthias Rath
    Abstract View Full Article View
    mendeley

    Synthesis of Some Aryl Ketoxime Derivatives with their in vitro Anti-microbial and Cytotoxic Activity

    DOI Logo 10.17352/gjct.000023

    Published On: March 08, 2019 | Pages: 001 - 006

    Author(s): Oguzhan Karaosmanoglu, Burcu Butun*, Hakan Dal, Hulya Sivas and Kadriye Benkli
    Abstract View Full Article View
    mendeley

    Total Oncology is necessary for Japanese new era

    DOI Logo 10.17352/2581-5407.000022

    Published On: October 13, 2018 | Pages: 001 - 003

    Author(s): Tsuyoshi Shirakawa*
    Abstract View Full Article View
    mendeley

    Video Endoscopic Inguinal Lymphadenectomy: Refi ning surgical technique after ten years experience

    DOI Logo 10.17352/gjct.000021

    Published On: December 30, 2017 | Pages: 034 - 037

    Author(s): Marcos Tobias-Machado, Pericles Rios Auad*, Victor Corona, Igor Silva, Oseas de Castro Neves, Eliney Ferreira Faria, Pablo Matos, Alexandre Cesar Santos, Roberto Machado, Aurus Dourado and Hamilton de Campos Zampolli
    Abstract View Full Article View
    mendeley

    Role of tumor heterogeneity in drug resistance

    DOI Logo 10.17352/gjct.000020

    Published On: July 20, 2017 | Pages: 032 - 033

    Author(s): Dhruv Kumar*
    Abstract View Full Article View
    mendeley

    MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer

    DOI Logo 10.17352/gjct.000019

    Published On: May 26, 2017 | Pages: 030 - 031

    Author(s): Julius Strauss*
    Abstract View Full Article View
    mendeley

    Angiosarcoma of the Scalp and Face: A Hard to Treat Tumor

    DOI Logo 10.17352/gjct.000018

    Published On: April 15, 2017 | Pages: 026 - 029

    Author(s): Jmour Omar*, Kochbati Lotfi , Ghith Sahar and Benna Farouk
    Abstract View Full Article View
    mendeley

    The Promise of Disease Management in Greece

    DOI Logo 10.17352/gjct.000017

    Published On: March 30, 2017 | Pages: 018 - 025

    Author(s): Konstantinos Stamatiou, Richard Lacroix, Eleni Almpani, Konstantinos Katsanos, Georgios Tzitzikos and Maria Saridi*
    Abstract View Full Article View
    mendeley

    Abrikossoff’s Tumour Mimicking a Neoplastic Tumour of the Breast: A Case Report

    DOI Logo 10.17352/gjct.000016

    Published On: March 20, 2017 | Pages: 015 - 017

    Author(s): Alassiri A*, Al Ali A, Vaysse C, Escourrou G, Vinet B and Rimailho J
    Abstract View Full Article View

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT